Ipsen
E645749
Ipsen is a global biopharmaceutical company headquartered in France, focused on specialty care areas such as oncology, neuroscience, and rare diseases.
All labels observed (3)
| Label | Occurrences |
|---|---|
| Ipsen canonical | 2 |
| Ipsen Biopharmaceuticals Inc. | 1 |
| Ipsen Pharma SAS | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T7157007 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Ipsen Context triple: [Exicure, Inc., hasCollaborationWith, Ipsen]
-
A.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
-
B.
Roche
Roche is a common surname of French origin borne by various notable individuals across fields such as architecture, politics, and the arts.
-
C.
Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
-
D.
Arthus-Bertrand
Arthus-Bertrand is the hyphenated French family name of photographer and environmentalist Yann Arthus-Bertrand, known for his aerial imagery and ecological advocacy.
-
E.
Sandoz
Sandoz is a historic Swiss pharmaceutical company best known as a predecessor of Novartis and a major player in generic medicines.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Ipsen Target entity description: Ipsen is a global biopharmaceutical company headquartered in France, focused on specialty care areas such as oncology, neuroscience, and rare diseases.
-
A.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
-
B.
Roche
Roche is a common surname of French origin borne by various notable individuals across fields such as architecture, politics, and the arts.
-
C.
Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
-
D.
Arthus-Bertrand
Arthus-Bertrand is the hyphenated French family name of photographer and environmentalist Yann Arthus-Bertrand, known for his aerial imagery and ecological advocacy.
-
E.
Sandoz
Sandoz is a historic Swiss pharmaceutical company best known as a predecessor of Novartis and a major player in generic medicines.
- F. None of above. chosen
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
biopharmaceutical company
ⓘ
public company ⓘ |
| country | France ⓘ |
| focusesOn |
neuroscience
ⓘ
oncology ⓘ rare diseases ⓘ specialty care ⓘ |
| foundedBy | Henri Beaufour ⓘ |
| hasMajorShareholder | Beaufour family ⓘ |
| hasOfficeIn |
Australia
ⓘ
Canada ⓘ China ⓘ Germany ⓘ Italy ⓘ Japan ⓘ Spain ⓘ United Kingdom ⓘ United States ⓘ
linked to:
United States of America
|
| hasRAndDCenterIn |
France
ⓘ
United Kingdom ⓘ United States ⓘ
linked to:
United States of America
|
| hasSubsidiary |
Ipsen Biopharmaceuticals Inc.
ⓘ
linked to:
Ipsen
Ipsen Pharma SAS ⓘ
linked to:
Ipsen
|
| headquartersLocation | Boulogne-Billancourt, France ⓘ |
| inception | 1929 ⓘ |
| industry |
biopharmaceuticals
ⓘ
pharmaceuticals ⓘ |
| isListedOn | CAC Mid 60 ⓘ |
| languageOfWorkOrName |
English
ⓘ
French ⓘ |
| legalForm | Société Anonyme ⓘ |
| product |
Cabometyx
ⓘ
Decapeptyl ⓘ Dysport ⓘ
linked to:
Botox (therapeutic and cosmetic)
Onivyde ⓘ
linked to:
irinotecan
Somatuline ⓘ |
| researchFocus |
innovative medicines
ⓘ
neuroscience ⓘ oncology ⓘ rare diseases ⓘ |
| stockExchange |
Euronext Paris
ⓘ
linked to:
Euronext
|
| therapeuticArea |
endocrine tumors
ⓘ
gastroenteropancreatic neuroendocrine tumors ⓘ movement disorders ⓘ neurotoxin treatments ⓘ prostate cancer ⓘ spasticity ⓘ |
| tickerSymbol | IPN ⓘ |
| website | https://www.ipsen.com ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Ipsen Description of subject: Ipsen is a global biopharmaceutical company headquartered in France, focused on specialty care areas such as oncology, neuroscience, and rare diseases.
Referenced by (4)
Full triples — surface form annotated when it differs from this entity's canonical label.
linked to: Ipsen
linked to: Ipsen